Literature DB >> 16282476

Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect.

Machiko Nishio1, Masato Tsurudome, Morihiro Ito, Yasuhiko Ito.   

Abstract

The V proteins of some paramyxoviruses have developed the ability to efficiently inactivate STAT protein function as a countermeasure for evading interferon (IFN) responses. Human parainfluenza virus type 4 (hPIV4) is one of the rubulaviruses, which are members of the family Paramyxoviridae, and has a V protein with a highly conserved cysteine-rich domain that is the hallmark of paramyxovirus V proteins. In order to study the function of the hPIV4 V protein, we established HeLa cells expressing the hPIV4A V protein (HeLa/FlagPIV4V). The hPIV4 V protein had no ability to reduce the level of STAT1 or STAT2, although it associated with STAT1, STAT2, DDB1, and Cul4A. It interfered with neither STAT1 and STAT2 tyrosine phosphorylation nor IFN-induced STAT nuclear accumulation. In addition, HeLa/FlagPIV4V cells are fully sensitive to both beta interferon (IFN-beta) and IFN-gamma, indicating that the hPIV4 V protein has no ability to block IFN-induced signaling. We further established HeLa cells expressing various chimeric proteins between the hPIV2 and hPIV4A V proteins. The lack of IFN-antagonistic activity of the hPIV4 V protein is caused by both the P/V common and V-specific domains. At least two regions (amino acids [aa] 32 to 45 and aa 143 to 164) of hPIV4 V in the P/V common domain and one region (aa 200 to 212) of the C terminus are involved in the inability to evade the IFN-induced signaling. Moreover, we established HeLa cells persistently infected with hPIV4 to make sure of the inability to escape IFN and confirmed that hPIV4 is the only paramyxovirus analyzed to date that can't evade the IFN-induced antiviral responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282476      PMCID: PMC1287573          DOI: 10.1128/JVI.79.23.14756-14768.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  ANTIGENIC VARIATION AMONG NEWLY ISOLATED STRAINS OF PARAINFLUENZA TYPE 4 VIRUS.

Authors:  J CANCHOLA; A J VARGOSKO; H W KIM; R H PARROTT; E CHRISTMAS; B JEFFRIES; R M CHANOCK
Journal:  Am J Hyg       Date:  1964-05

2.  The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection.

Authors:  P Latorre; T Cadd; M Itoh; J Curran; D Kolakofsky
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

3.  C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein.

Authors:  Noriko Yokosawa; Shin-Ichi Yokota; Toru Kubota; Nobuhiro Fujii
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.

Authors:  D Garcin; P Latorre; D Kolakofsky
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses.

Authors:  B Gotoh; K Takeuchi; T Komatsu; J Yokoo; Y Kimura; A Kurotani; A Kato; Y Nagai
Journal:  FEBS Lett       Date:  1999-10-08       Impact factor: 4.124

7.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Sequence analyses of human parainfluenza virus type 4A and type 4B fusion proteins.

Authors:  H Komada; H Bando; M Ito; H Ohta; M Kawano; M Nishio; M Tsurudome; N Watanabe; N Ikemura; S Kusagawa
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

9.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

Authors:  A García-Sastre; A Egorov; D Matassov; S Brandt; D E Levy; J E Durbin; P Palese; T Muster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

10.  The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein.

Authors:  G Y Lin; R G Paterson; C D Richardson; R A Lamb
Journal:  Virology       Date:  1998-09-15       Impact factor: 3.616

View more
  14 in total

Review 1.  Paramyxovirus disruption of interferon signal transduction: STATus report.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 2.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

Review 3.  Pathogenesis of acute respiratory illness caused by human parainfluenza viruses.

Authors:  Henrick Schomacker; Anne Schaap-Nutt; Peter L Collins; Alexander C Schmidt
Journal:  Curr Opin Virol       Date:  2012-03-03       Impact factor: 7.090

4.  Tetherin antagonism by V proteins is a common trait among the genus Rubulavirus.

Authors:  Keisuke Ohta; Yusuke Matsumoto; Morihiro Ito; Machiko Nishio
Journal:  Med Microbiol Immunol       Date:  2017-05-02       Impact factor: 3.402

5.  Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs.

Authors:  K Hagmaier; N Stock; B Precious; K Childs; L-F Wang; S Goodbourn; R E Randall
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

6.  La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation.

Authors:  Giuseppe Pisanelli; Maudry Laurent-Rolle; Balaji Manicassamy; Alan Belicha-Villanueva; Juliet Morrison; Bernardo Lozano-Dubernard; Felipa Castro-Peralta; Giuseppe Iovane; Adolfo García-Sastre
Journal:  Virus Res       Date:  2015-11-03       Impact factor: 3.303

7.  The V protein of Tioman virus is incapable of blocking type I interferon signaling in human cells.

Authors:  Grégory Caignard; Marianne Lucas-Hourani; Kevin P Dhondt; Jean-Louis Labernardière; Thierry Petit; Yves Jacob; Branka Horvat; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

8.  Antagonism of innate immunity by paramyxovirus accessory proteins.

Authors:  Raychel Chambers; Toru Takimoto
Journal:  Viruses       Date:  2009-10-28       Impact factor: 5.818

9.  Detecting remote sequence homology in disordered proteins: discovery of conserved motifs in the N-termini of Mononegavirales phosphoproteins.

Authors:  David Karlin; Robert Belshaw
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 10.  Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene.

Authors:  Jordan Douglas; Alexei J Drummond; Richard L Kingston
Journal:  Virus Evol       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.